Supplementary Notes on Somatostatin Venom Analogs by Cone Snails

  • Study Focus

    • Investigates venom analogs of somatostatin (SS) evolved by fish-hunting cone snails.

    • Aims to link predatory behavior with the identification of potential drug leads.

  • Key Contributors

    • Iris Bea L. Ramiro, Walden E. Bjørn-Yoshimoto, Julita S. Imperial, et al.

    • Published in Science Advances, March 2022, DOI: 10.1126/sciadv.abk1410

  • Figures & Explanations

    • Fig. S1: Mass determination confirms molecular mass of Consomatin Ro1 variant.

    • Techniques used: Edman degradation, transcriptome analysis.

    • Fig. S2: Reverse-phase elution profiles display behavior of Consomatin Ro1 against other variants.

    • Fig. S3: Precursor sequences of Consomatin Ro1 align with other consomatins showing signal peptides and predicted mature toxins.

    • Red regions: Predicted mature toxin encoding.

    • Data obtained using SignalP and PeptideCutter software.

    • Fig. S4: Stability profiles for human SS-14 and Consomatin Ro1 over 24 hours observed via LC/MS peak area analysis.

    • Fig. S5: Structures of Consomatin Ro1 in crystal formation showcasing interactions and stacking arrangements critical for molecular stability and alignment.

    • Unique orientation due to PEG interactions.

    • Fig. S6: Multiple views of Consomatin Ro1 in a crystal structure highlighting differences in residue orientations.

    • Fig. S7: Calcium signal responses in zebrafish CNS neurons showing varying responses to Consomatin Ro1 and somatostatin, suggesting bioactivity.

    • 14.14% of neurons responded to Consomatin Ro1.

  • Tables Summarized

    • Table S1: Timeline of predation events for Conus neocostatus detailing behaviors captured in various video segments.

    • Table S2: Analysis of C. rolani venom fractions showing bioactivity in mice with detailed behavioral outcomes post-injection.

    • Table S3: Crystallographic data for Consomatin Ro1 and its refinement statistics including resolution and reflections measured, giving insights into molecular structure analysis.

    • Table S4: EC50 values for human somatostatins and related consomatins at SST1-5 receptors, indicating compound potency.

    • Table S5: Overview of venom gland transcriptome datasets used for SS-like sequence identification across various Conus species.

  • Movie Insights

    • Movies S1-S6: Document various hunting strategies of cone snails, including taser-and-tether, net-hunting, and ambush techniques, emphasizing their predation mechanics.

Results

  • Bioactivity of Consomatin Ro1:

    • 14.14% of zebrafish CNS neurons showed a response to Consomatin Ro1, indicating significant bioactivity.

    • The calcium signal responses in the neurons suggest that Consomatin Ro1 is capable of modulating neuronal activity similarly to somatostatin.

  • Stability Profiles:

    • LC/MS peak area analysis revealed that Consomatin Ro1 maintained stability over a 24-hour period, which is critical for potential therapeutic applications.

  • Structural Insights:

    • Crystallographic data of Consomatin Ro1 showed unique stacking arrangements and interactions due to PEG, which may influence its stability and function.

    • Multiple structural views highlight differences in residue orientations, suggesting specific conformations are important for activity.

Key Data

  • Fig. S1: Mass determination confirms the molecular mass of Consomatin Ro1.

  • Fig. S4: Stability profiles comparing human SS-14 and Consomatin Ro1, indicating favorable stability for Consomatin Ro1.

  • Table S4: EC50 values at SST1-5 receptors show the potency of Consomatin Ro1 compared to human somatostatins, providing quantitative insights on its effectiveness.

  • Table S5: Overview of venom gland transcriptome datasets, emphasizing the extensive diversity and potential for SS-like sequence identification across various Conus species.

Background

  • Cone snails are known for their complex venom, which includes various bioactive peptides.

  • Venom analogs of somatostatin evolved by fish-hunting cone snails are of specific interest for their potential medicinal properties.

Past Observations

  • Previous studies indicated that cone snail venoms can influence neuronal signaling and have applications in pain management and other therapeutic areas.

  • Early insights show that somatostatin-related peptides might hold similar bioactivity.

Problem

  • The challenge lies in identifying new compounds that can effectively mimic or enhance the neuropharmacological effects of somatostatin.

  • Additionally, understanding the structural basis for the activity of these peptides remains limited.

Question

  • Can the identified venom analog Consomatin Ro1 exhibit bioactivity similar to that of somatostatin, and what structural features contribute to its function?

Hypothesis

  • Consomatin Ro1 will display bioactive properties comparable to somatostatin due to its structural similarity and unique evolutionary adaptations in the cone snail venom.

Approach

  • To test the hypothesis, the study will evaluate the biological activity of Consomatin Ro1 in various experimental models, particularly focusing on neuroactivity and stability profiles.

  • This includes comparing responses in neuronal signaling assays to those evoked by somatostatin.

Methods

  • The study will employ Edman degradation and transcriptome analysis to determine the molecular characteristics of Consomatin Ro1.

  • Techniques like LC/MS for stability analysis and calcium signaling assays in zebrafish CNS neurons will be used to assess bioactivity.

  • Crystallographic analysis will provide insights into its structural properties.

Results

  • Bioactivity of Consomatin Ro1:

    • 14.14% of zebrafish CNS neurons showed a response to Consomatin Ro1, indicating significant bioactivity.

    • The calcium signal responses in the neurons suggest that Consomatin Ro1 is capable of modulating neuronal activity similarly to somatostatin.

  • Stability Profiles:

    • LC/MS peak area analysis revealed that Consomatin Ro1 maintained stability over a 24-hour period, which is critical for potential therapeutic applications.

  • Structural Insights:

    • Crystallographic data of Consomatin Ro1 showed unique stacking arrangements and interactions due to PEG, which may influence its stability and function.

    • Multiple structural views highlight differences in residue orientations, suggesting specific conformations are important for activity.